{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Irvine",
      "address_1": "2525 Dupont Dr",
      "reason_for_recall": "The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.",
      "address_2": "",
      "product_quantity": "4,026,287 Breast Implants and Tissue Expanders Combined in total",
      "code_info": "ALL LOTS       Product Code/UDI  STYLE 110:110-090 10888628002159,  110-120 10888628002166,  110-150 10888628002173,  110-180 10888628002180,  110-210 10888628002197,  110-240 10888628002203,  110-270 10888628002210,  110-300 10888628002227,  110-330 10888628002234,  110-360 10888628002241,  110-390 10888628002258,  110-420 10888628002265,  110-450 10888628002272,  110-480 10888628002289,  110-510 10888628002296;    STYLE 115:115-150 10888628002302,  115-167 10888628002319,  115-185 10888628002326,  115-203 10888628002333,  115-222 10888628002340,  115-253 10888628002357,  115-272 10888628002364,  115-290 10888628002371,  115-322 10888628002388,  115-354 10888628002395,  115-378 10888628002401,  115-401 10888628002418,  115-435 10888628002425,  115-469 10888628002432,  115-507 10888628002449,  115-547 10888628002456,  115-586 10888628002463,  115-627 10888628002470,  115-666 10888628002487,  115-716 10888628002494;    STYLE 120:120-180 10888628002500,  120-220 10888628002517,  120-260 10888628002524,  120-300 10888628002531,  120-340 10888628002548,  120-400 10888628002555,  120-440 10888628002562,  120-500 10888628002579,  120-550 10888628002586,  120-600 10888628002593,  120-650 10888628002609;",
      "center_classification_date": "20190911",
      "distribution_pattern": "Worldwide Distribution and US Nationwide     All fifty (50) US States,  the US Virgin Islands and Puerto Rico.  (AK, AL, AR, AZ, CA,  CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY).    OUS: Bermuda, Canada, Chile, Japan, Korea, Thailand, Taiwan and Vietnam.",
      "state": "CA",
      "product_description": "Natrelle and McGhan Silicone-Filled Breast Implant BioCell Round Moderate Profile, Sterile, for the following style numbers:  Style 110:110-090,  110-120,  110-150,  110-180,  110-210,  110-240,  110-270,  110-300,  110-330,  110-360,  110-390,  110-420,  110-450,  110-480,  110-510;    Style 115 :115-150,  115-167,  115-185,  115-203,  115-222,  115-253,  115-272,  115-290,  115-322,  115-354,  115-378,  115-401,  115-435,  115-469,  115-507,  115-547,  115-586,  115-627,  115-666,  115-716;    Style 120: 120-180,  120-220,  120-260,  120-300,  120-340,  120-400,  120-440,  120-500,  120-550,  120-600,  120-650;    These products may have been sold under the McGhan, Inamed or NATRELLE brands.        Product Usage:   Breast augmentation and Breast reconstruction",
      "report_date": "20190918",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Allergan PLC",
      "recall_number": "Z-2454-2019",
      "initial_firm_notification": "Press Release",
      "product_type": "Devices",
      "event_id": "83500",
      "more_code_info": "",
      "recall_initiation_date": "20190724",
      "postal_code": "92612-1531",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Ongoing"
    }
  ]
}